Advances in Current BiologyAdvances in Current BiologyУспехи современной биологии0042-13243034-6347The Russian Academy of Sciences65319910.31857/S0042132424030033PSBEEYArticlesСтатьиResearch ArticleHuman Health, Environmental Comfort and Well-Being. Part 1. Engineering and Design Resources of the Bioindustry on the Way to Safe Competition with the Resources of Natural Biocenoses and Health-Saving SystemsЗдоровье, экологический комфорт и благополучие человека. Часть 1. Инженерно-дизайнерские ресурсы биоиндустрии на пути к безопасной конкуренции с ресурсами природных биоценозов и систем здоровьесбереженияSuchkovS. V.СучковС. В.
Russian Federation

Department of Clinical Allergology and Immunology

кафедра клинической аллергологии и иммунологии

med_nika2000@mail.ruAbeH.АбэХ.
Japan
med_nika2000@mail.ruMurphyS.МёрфиШ.
United States
med_nika2000@mail.ruSmithD.СмитД.
United States
med_nika2000@mail.ruPolyakovaV. S.ПоляковаВ. С.
Russian Federation
med_nika2000@mail.ruSchermanD.ШерманД.
Belgium

Unité de Pharmacologie Chimique et Génétique d’Imagerie

отделение химической фармакологии и генетики визуализации

med_nika2000@mail.ruGlinushkinA. P.ГлинушкинА. П.
Russian Federation
med_nika2000@mail.ruBarachP.БарахП.
United States
mbikeeva@yandex.ruTerentʼevA. O.ТерентьевА. О.
Russian Federation
mbikeeva@yandex.ruTanM.ТанМ.
Japan
mbikeeva@yandex.ruSuvorovA. N.СуворовА. Н.
Russian Federation

Department of Microbiology

кафедра микробиологии СПбГУ

mbikeeva@yandex.ruRussian Academy of Natural SciencesРоссийская академия естественных наукRussian University of MedicineРоссийский университет медициныNew York Academy of SciencesНью-Йоркская академия наукUniversity of World Politics and LawУниверситет мировой политики и праваAbe Cancer ClinicОнкологическая клиника АбэMassachusetts General Hospital (MGH)Массачусетская больница общего профиляHarvard Medical SchoolМедицинская школа ГарвардаMayo ClinicКлиника МэйоEuropean Academy of SciencesЕвропейская академия наукNational Center for Scientific Research (CNRS)Национальный центр научных исследованийParis Descartes UniversityУниверситет ДекартаZelinsky Institute of Organic Chemistry, Russian Academy of SciencesИнститут органической химии им. Н.Д. Зелинского РАНWayne State University, School of MedicineМедицинская школа Университета штата УэйнNAKADA Geriatric Health and Welfare FacilitiesГериатрические учреждения здравоохранения и социального обеспечения НакадаInstitute of Experimental Medicine, Russian Academy of SciencesИнститут экспериментальной медицины РАНSt. Petersburg State UniversityСанкт-Петербургский государственный университет18052024144329131302022025Copyright ©; 2024, Russian Academy of SciencesCopyright ©; 2024, Российская академия наук2024Russian Academy of SciencesРоссийская академия наукhttps://journals.eco-vector.com/0042-1324/article/view/653199

Everyone has the right to the highest attainable standard of health, and modern preventive, preventive and rehabilitative manipulations promote health and well-being. Thanks to a number of fundamental projects on the study of human health at various levels (genomic, proteomic, and metabolomic), and molecular mechanisms of the development of pathological conditions, there has been a great leap in the field of applied sectors of industrial biotechnology, including segments of the pharmaceutical and food industries, significantly replenished health-saving resources and improved the quality of life of the population. This article will review the advanced achievements of fundamental and applied research, as well as promising areas of the bioindustry.

Каждый человек имеет право на наивысший достижимый уровень здоровья, а современные превентивно-профилактические и реабилитационные манипуляции способствуют укреплению здоровья и благополучия. Благодаря ряду фундаментальных проектов по изучению здоровья человека на различных уровнях (геномном, протеомном и метаболомном) и молекулярных механизмов развития патологических состояний произошел большой скачок в области прикладных секторов промышленной биотехнологии, включая сегменты фармацевтической и пищевой индустрии, существенно пополнив ресурсы здоровьесбережения и повысив качество жизни населения.В данном обзоре будут рассмотрены передовые достижения фундаментально-прикладных исследований, а также перспективные направления биоиндустрии.

personalized and precision medicinetranslational developmentsnutritionologybiodesignbioinformaticsbiotechnologygeneticsперсонализированная и прецизионная медицинатрансляционные разработкинутрициологиябиодизайнбиоинформатикабиотехнологиягенетикаОсновы персонализированной и прецизионной медицины / Ред. С.В. Сучков. М.: ГЭОТАР-Медиа, 2020. 624 с.Секачева Е.Г., Большакова О.В., Бондаренко В.В. Применение методов клеточной и генной инженерии в биологии и медицине // Синергия Наук. 2018. № 23. С. 980–992.Arslan F.1., Lai R.C., Smeets M.B. et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury // Stem Cell Res. 2013. V. 10 (3). P. 301–312. https://doi.org/10.1016/j.scr.2013.01.002Bailey R.M., Rozenberg A., Gray S.J. Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies // Brain Res. 2020. V. 1739. P. 146832. https://doi.org/10.1016/j.brainres.2020.146832Balashova E.E., Trifonova O.P., Maslov D.L. et al. Metabolomnoe profilirovanie v izuchenii protsessov stareniia [Metabolome profiling in the study of aging processes] // Biomed. Khim. 2022. V. 68 (5). P. 321–338. https://doi.org/10.18097/PBMC20226805321Bashor C.J., Hilton I.B., Bandukwala H. et al. Engineering the next generation of cell-based therapeutics // Nat. Rev. Drug Discov. 2022. V. 21. P. 655–675.Basler G., Fernie A.R., Nikoloski Z. Advances in metabolic flux analysis toward genome-scale profiling of higher organisms // Biosci. Rep. 2018. V. 38 (6). P. BSR20170224. https://doi.org/10.1042/BSR20170224Beckonert O., Keun H., Ebbels T. et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts // Nat. Protoc. 2007. V. 2. P. 2692–2703.Bodrova T.A., Kostyushev D.S., Antonova E.N. et al. Introduction into PPPM as a new paradigm of public health service: an integrative view // EPMA J. 2012. V. 3 (1). P. 16.Bollini S., Smart N., Riley P.R. Resident cardiac progenitor cells: at the heart of regeneration // J. Mol. Cell Cardiol. 2011. V. 50 (2). P. 296–303. https://doi.org/10.1016/j.yjmcc.2010.07.006Chappell C.R., Perez R., Takara C.O. Growing biodesign ecosystems: community exchange spaces advance biotechnology innovation // Res. Direct. Biotechnol. Design. 2023. V. 1. P. e13. https://doi.org/10.1017/btd.2023.8Carrillo-Rodriguez P., Selheim F., Hernandez-Valladares M. Mass spectrometry-based proteomics workflows in cancer research: the relevance of choosing the right steps // Cancers (Basel). 2023. V. 15 (2). P. 555. https://doi.org/10.3390/cancers15020555Castelli F.A., Rosati G., Moguet C. et al. Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests // Anal. Bioanal. Chem. 2022. V. 414 (2). P. 759–789. https://doi.org/10.1007/s00216-021-03586-zClarke C.J., Haselden J.N. Metabolic profiling as a tool for understanding mechanisms of toxicity // Toxicol. Pathol. 2008. V. 36 (1). P. 140–147.Cui H., Miao S., Esworthy T. et al. 3D bioprinting for cardiovascular regeneration and pharmacology // Adv. Drug. Deliv. Rev. 2018. V. 132. P. 252–269. https://doi.org/10.1016/j.addr.2018.07.014Dang D.K., Park B.H. Circulating tumor DNA: current challenges for clinical utility // J. Clin. Invest. 2022. V. 132 (12). P. e154941. https://doi.org/10.1172/JCI154941Dietrich E., Antoniades K. Molecularly targeted drugs for the treatment of cancer: oral complications and pathophysiology // Hippokratia. 2012. V. 16 (3). P. 196–199.Dromms R.A., Styczynski M.P. Systematic applications of metabolomics in metabolic engineering // Metabolites. 2012. V. 2 (4). P. 1090–1122.Ellis J.K., Athersuch T.J., Thomas L.D. et al. Metabolic profiling detects early effects of environmental and lifestyle exposure to cadmium in a human population // BMC Med. 2012. V. 10. P. 61.Ellison G.M., Vicinanza C., Smith A.J. et al. Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair // Cell. 2013. V. 154 (4). P. 827–842. https://doi.org/10.1016/j.cell.2013.07.039Fodor W.L. Tissue engineering and cell based therapies, from the bench to the clinic: the potential to replace, repair and regenerate // Reprod. Biol. Endocrinol. 2003. V. 1. P. 102.Gu W., Hasan S., Rocca-Serra P., Satagopam V.P. Road to effective data curation for translational research // Drug Discov. Today. 2021. V. 26 (3). P. 626–630. https://doi.org/10.1016/j.drudis.2020.12.007Hulke M.L., Massey D.J., Koren A. Genomic methods for measuring DNA replication dynamics // Chromosome Res. 2020. V. 28 (1). P. 49–67. https://doi.org/10.1007/s10577-019-09624-yIrvine D.J., Maus M.V., Mooney D.J., Wong W.W. The future of engineered immune cell therapies // Science. 2022. V. 378 (6622). P. 853–858. https://doi.org/10.1126/science.abq6990Jiang S., Liberti L., Lebo D. Direct-to-consumer genetic testing: a comprehensive review // Ther. Innov. Reg. Sci. 2023. V. 57 (6). P. 1190–1198.Kantor A., McClements M.E., MacLaren R.E. CRISPR-Cas9 DNA base-editing and prime-editing // Int. J. Mol. Sci. 2020. V. 21 (17). P. 6240. https://doi.org/10.3390/ijms21176240Kapoor S., Rafiq A., Sharma S. Protein engineering and its applications in food industry // Crit. Rev. Food Sci. Nutr. 2017. V. 57 (11). P. 2321–2329. https://doi.org/10.1080/10408398.2014.1000481Khanijou J.K., Kulyk H., Bergès C. et al. Metabolomics and modelling approaches for systems metabolic engineering // Metab. Eng. Commun. 2022. V. 15. P. e00209.King R.S., Newmark P.A. The cell biology of regeneration // J. Cell Biol. 2012. V. 196 (5). P. 553–562. https://doi.org/10.1083/jcb.201105099Liang K., Du Y. Cell engineering techniques improve pharmacology of cellular therapeutics // Biomater. Biosyst. 2021. V. 2. 100016.Lizak N., Malpas C.B., Sharmin S. et al. Association of sustained immunotherapy with disability outcomes in patients with active secondary progressive multiple sclerosis // JAMA Neurol. 2020. V. 77 (11). P. 1398.Lutz S., Iamurri S.M. Protein engineering: past, present, and future // Meth. Mol. Biol. 2018. V. 1685. P. 1–12. https://doi.org/10.1007/978-1-4939-7366-8_1Ma L., Yang H. What’s next toward the bio-design and manufacturing field? // Bio-Des. Manuf. 2023. V. 6. P. 735–741. https://doi.org/10.1007/s42242-023-00260-4Mann S.P., Treit P.V., Geyer P.E. et al. Ethical principles, constraints and opportunities in clinical proteomics // Mol. Cell Proteom. 2021. V. 20. P. 100046. https://doi.org/10.1016/j.mcpro.2021.100046Medvedeva V., Sorenson E.J., Studneva M. et al. The autoimmune syndrome through the prism of targeted AT-mediated proteolysis: innovative ideas, philosophy, and tools for practitioners of the next step generation // Am. J. Biomed. Sci. Res. 2022a. V. 15 (3). P. 319–327.Medvedeva V., Rose N., Miller A. D. et al. The editorials: towards integrated biodesign-related and translational platforms to determine co-development for adaptation of innovative biotechnologies and to prognosticate the future of the healthcare and life science bioindustry // British J. Health. Med. Res. 2022b. V. 9 (4). 271–281.Mendell J.R., Al-Zaidy S., Shell R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy // N. Engl. J. Med. 2017 V. 377 (18). P. 1713–1722. https://doi.org/10.1056/NEJMoa1706198. PMID: 29091557Mitsuishi M., Cao J., Bártolo P. et al. Biomanufacturing // CIRP Ann. 2013. V. 62 (2). P. 585–606.Neely B.A., Dorfer V., Martens L. et al. Toward an integrated machine learning model of a proteomics experiment // J. Prot. Res. 2023. V. 22 (3). P. 681–696. https://doi.org/10.1021/acs.jproteome.2c00711Oh B. Direct-to-consumer genetic testing: advantages and pitfalls // Genom. Inform. 2019. V. 17 (3). P. e33. https://doi.org/10.5808/GI.2019.17.3.e33Perin E., Borow K., Henry T. et al. Randomized trial of targeted transendocardial mesenchymal precursor cell therapy in patients with heart failure // J. Am. Coll. Cardiol. 2023. V. 81 (9). P. 849–863. https://doi.org/10.1016/j.jacc.2022.11.061Santos A., Colaço A.R., Nielsen A.B. et al. A knowledge graph to interpret clinical proteomics data // Nat. Biotechnol. 2022. V. 40 (5). P. 692–702. https://doi.org/10.1038/s41587-021-01145-6Saw P.E., Song E.W. Phage display screening of therapeutic peptide for cancer targeting and therapy // Prot. Cell. 2019. V. 10 (11). P. 787–807. https://doi.org/10.1007/s13238-019-0639-7Shah S.H., Kraus W.E., Newgard C.B. Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function // Circulation. 2012. V. 126 (9). P. 1110–1120.Shuel S.L. Targeted cancer therapies: clinical pearls for primary care // Can. Fam. Physician. 2022. V. 68 (7). P. 515–518.Simons M., Raposo G. Exosomes – vesicular carriers for intercellular communication // Curr. Opin. Cell Biol. 2009. V. 21 (4). P. 575–581.Singh R.K., Lee J.K., Selvaraj C. et al. Protein engineering approaches in the post-genomic era // Curr. Prot. Pept. Sci. 2018. V. 19 (1). P. 5–15. https://doi.org/10.2174/1389203718666161117114243Smith R.R., Lucio Barile L., Cho H.C. et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens // Circulation. 2007. V. 115 (7). P. 896–908. https://doi.org/10.1161/CIRCULATIONAHA.106.655209Sterner R.C., Sterner R.M. CAR-T cell therapy: current limitations and potential strategies // Blood Cancer J. 2021. V. 11 (4). P. 69. https://doi.org/10.1038/s41408-021-00459-7Studneva M., Rose N., Gabibov A. et al. A new generation of translational tools designed to monitor multiple sclerosis (MS) at clinical and subclinical stages // Med. Med. Sci. 2021. V. 1 (5). P. 55–63.Suchkov S., Murphy S., Smith D., et al. Perspective: personalized and precision medicine (PPM) hold the hi-tech future for healthcare via biodesign to secure the human healthcare and biosafety // World J. Mol. Med. 2024a. V. 1 (1). P. 1–9.Suchkov S., Scherman D., Bonifazi D. et al. Personalized and precision medicine (PPM) as a unique healthcare model of the next step generation: the role of a nurses and nursing practice in transdisciplinary care team: the future of nursing services // J. Med. Clin. Nurs. Stud. 2024b. V. 1 (1). P. 1–13.Volk M.J., Tran V.G., Tan S.I. et al. Metabolic engineering: methodologies and applications // Chem. Rev. 2023. V. 123 (9). P. 5521–5570. https://doi.org/10.1021/acs.chemrev.2c00403Wang S.W., Gao C., Zheng Y.M. et al. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer // Mol. Cancer. 2022. V. 21 (1). P. 57. https://doi.org/10.1186/s12943-022-01518-8Xu Y., Ritchie S.C., Liang Y. et al. An atlas of genetic scores to predict multi-omic traits // Nature. 2023. V. 616 (7955). P. 123–131. https://doi.org/10.1038/s41586-023-05844-9Yang S., Zhu Z., Chen S. et al. Metabolic fingerprinting on retinal pigment epithelium thickness for individualized risk stratification of type 2 diabetes mellitus // Nat. Comm. 2023. V. 14 (1). P. 6573. https://doi.org/10.1038/s41467-023-42404-1Yang K.K., Wu Z., Arnold F.H. Machine-learning-guided directed evolution for protein engineering // Nat. Methods. 2019. V. 16 (8). P. 687–694. https://doi.org/10.1038/s41592-019-0496-6Zhang C., Quan R., Wang J. Development and application of CRISPR/Cas9 technologies in genomic editing // Hum. Mol. Genet. 2018. V. 27 (R2). P. R79–R88. https://doi.org/10.1093/hmg/ddy120Zhang P., Wu W., Chen Q., Chen M. Non-coding RNAs and their integrated networks // J. Integr. Bioinform. 2019. V. 16 (3). P. 20190027. https://doi.org/10.1515/jib-2019-0027Zhao N., Song Y., Xie X. et al. Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development // Signal Transduct. Target Ther. 2023. V. 8 (1). P. 112. https://doi.org/10.1038/s41392-023-01375-x